Clinical Trial: Oral N-acetylcysteine for Retinitis Pigmentosa
Study Status: Completed
Recruit Status: RECRUITING
Condition: Retinitis Pigmentosa
Study Type: INTERVENTIONAL
Official Title: NAC Attack, A Phase III, Multicenter, Randomized, Parallel, Double Masked, Placebo-Controlled Study Evaluating the Efficacy and Safety of Oral N-Acetylcysteine in Patients With Retinitis Pigmentosa
Brief Summary:
Retinitis pigmentosa (RP) is an inherited retinal degeneration caused by one of several mistakes in the genetic code.Such mistakes are called mutations.The mutations cause degeneration of rod photoreceptors which are responsible for vision in dim illumination resulting in night blindness.After rod photoreceptors are eliminated, gradual degeneration of cone photoreceptors occurs resulting in gradual constriction of side vision that eventually causes tunnel vision.Oxidative stress contributes to cone…
Read more